LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Zimmer Biomet Holdings Inc

Cerrado

SectorSanidad

86.71 1.92

Resumen

Variación precio

24h

Actual

Mínimo

85

Máximo

88

Métricas clave

By Trading Economics

Ingresos

99M

239M

Ventas

-157M

2.1B

P/B

Media del Sector

21.487

49.888

BPA

2.09

Rentabilidad por dividendo

1.17

Margen de beneficios

11.43

Empleados

17,000

EBITDA

84M

538M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+14.05% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.17%

2.38%

Próximas Ganancias

6 ago 2026

Fecha Próximo Dividendo

31 jul 2026

Próxima Fecha de Ex Dividendo

25 jun 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.9B

16B

Apertura anterior

84.79

Cierre anterior

86.71

Noticias sobre sentimiento de mercado

By Acuity

14%

86%

20 / 344 Clasificación en Healthcare

Zimmer Biomet Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 nov 2025, 19:38 UTC

Ganancias

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Ganancias

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Comparación entre iguales

Cambio de precio

Zimmer Biomet Holdings Inc previsión

Precio Objetivo

By TipRanks

14.05% repunte

Estimación a 12 Meses

Media 96.92 USD  14.05%

Máximo 109 USD

Mínimo 83 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zimmer Biomet Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

16 ratings

4

Comprar

11

Mantener

1

Vender

Sentimiento

By Acuity

20 / 344 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat